Johnson and Johnson will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, July 17, to review second-quarter results. Alex Gorsky, Chairman...
Pfizer Inc. invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT...
Sanofi and Ablynx announced that Sanofi has now acquired all outstanding shares [including shares represented by American Depositary Shares (ADSs)], warrants and convertible bonds (together, the...
Vanguard announced a new framework, jointly developed with Mercer, that helps pre-retirees and retirees better understand the financial planning implications of annual health care costs and...
Humacyte, an innovator in biotechnology and regenerative medicine, announced today that Jeffrey Lawson MD, PhD has been appointed President and Chief Executive Officer. Carrie S. Cox...
Thermo Fisher Scientific announced the launch of its Ion AmpliSeq HD technology, the latest next-generation library preparation innovation that, for the first time, provides clinical researchers...
Alcon, the global leader in eye care and a division of Novartis, unveils new data showing significantly improved near and intermediate distance vision with the AcrySof...
At the International Society of Magnetic Resonance in Medicine Conference, Bruker announced the launch of the next version of its preclinical imaging software, ParaVision 360. It...
Haemonetics Corporation announced that the Company has entered into a new USD 700 million credit agreement with its lenders, comprised of a USD 350 million senior unsecured term loan A...
Quest Analytics, the leading provider of network access and adequacy services to health plans and insurance regulatory agencies, today announced that it has acquired BetterDoctor, the...
Merck, a leading science and technology company, announced the presentation of new efficacy and benefit-risk assessment data for MAVENCLAD (Cladribine Tablets) at the 4th Congress of the European...
The board of directors of Eli Lilly and Company has declared a dividend for the third quarter of 2018 of USD 0.5625 per share on outstanding common stock....
PerkinElmer, Inc., a global leader committed to innovating for a healthier world, announced that its EUROIMMUN Crithidia luciliae immunofluorescence test (CLIFT) and CLIFT sensitive assays have...
Allogene Therapeutics, Inc., a biotechnology company with a mission to catalyze the next revolution of cell therapy through the advancement of allogeneic CAR-T therapies, announced the...
Novartis announced 14-month results from the pivotal JULIET clinical trial showing ongoing durable responses are achievable with Kymriah (tisagenlecleucel) when administered to adult patients with relapsed or refractory...
Copyright © 2024 Medical Buyer